These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23834924)

  • 1. Review of vasodilators in acute decompensated heart failure: the old and the new.
    Carlson MD; Eckman PM
    J Card Fail; 2013 Jul; 19(7):478-93. PubMed ID: 23834924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of current noninodilator therapies for acute heart failure syndromes.
    Stough WG; O'Connor CM; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):41G-6G. PubMed ID: 16181822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing outcomes in the patient with acute decompensated heart failure.
    Mehra MR
    Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital policies for treatment of acute decompensated heart failure.
    Vats V; DiDomenico RJ; Wojtynek JE; Theobald JC; Schumock GT
    Ann Pharmacother; 2007 Apr; 41(4):562-7. PubMed ID: 17374618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for acute decompensated heart failure.
    Southworth MR
    Am J Health Syst Pharm; 2003 Aug; 60 Suppl 4():S7-15. PubMed ID: 12966901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of new medical treatments for acute decompensated heart failure.
    Teerlink JR
    Heart Fail Monit; 2002; 2(4):129-37. PubMed ID: 12634887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute decompensated heart failure: evolving literature and implications for future practice.
    Cicci JD; Reed BN; McNeely EB; Oni-Orisan A; Patterson JH; Rodgers JE
    Pharmacotherapy; 2014; 34(4):373-88. PubMed ID: 24214219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute decompensated heart failure: update on new and emerging evidence and directions for future research.
    Givertz MM; Teerlink JR; Albert NM; Westlake Canary CA; Collins SP; Colvin-Adams M; Ezekowitz JA; Fang JC; Hernandez AF; Katz SD; Krishnamani R; Stough WG; Walsh MN; Butler J; Carson PE; Dimarco JP; Hershberger RE; Rogers JG; Spertus JA; Stevenson WG; Sweitzer NK; Tang WH; Starling RC
    J Card Fail; 2013 Jun; 19(6):371-89. PubMed ID: 23743486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute decompensated heart failure in an evidence-based era: what is the evidence behind the current standard of care?
    Fares WH
    Heart Lung; 2008; 37(3):173-8. PubMed ID: 18482628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chemical pharmacotherapy for managing acute decompensated heart failure.
    Yandrapalli S; Tariq S; Aronow WS
    Expert Opin Pharmacother; 2017 Apr; 18(5):471-485. PubMed ID: 28276970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Abraham WT; Adams KF; Fonarow GC; Costanzo MR; Berkowitz RL; LeJemtel TH; Cheng ML; Wynne J; ;
    J Am Coll Cardiol; 2005 Jul; 46(1):57-64. PubMed ID: 15992636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for acute decompensated heart failure treatment.
    DiDomenico RJ; Park HY; Southworth MR; Eyrich HM; Lewis RK; Finley JM; Schumock GT
    Ann Pharmacother; 2004 Apr; 38(4):649-60. PubMed ID: 14982975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of randomized clinical trials in acute heart failure syndromes.
    Teerlink JR
    Am J Cardiol; 2005 Sep; 96(6A):59G-67G. PubMed ID: 16181824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nesiritide in acute decompensated heart failure: current status and future perspectives.
    Mohammed SF; Korinek J; Chen HH; Burnett JC; Redfield MM
    Rev Cardiovasc Med; 2008; 9(3):151-8. PubMed ID: 18953274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.